Clinical Trial Update: Dendritic Killer Cell-based Immunotherapy for Solid Tumors [Phase 1]

View source ↗

Summary

An ongoing Phase 1 clinical trial of a dendritic killer cell–based immunotherapy for solid tumors is described, with colorectal neoplasms and hepatocellular car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms
• Hepatocellular Carcinoma

Drugs mentioned

• Dendritic Killer Cell-based Immunotherapy

Snippet

Sponsor: FullHope Biomedical Co., Ltd. | Conditions: Colorectal Neoplasms, Hepatocellular Carcinoma | Phase 1 | Status: UNKNOWN